PROVECTUS BIOPHARMACEUTICALS
Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer.
PROVECTUS BIOPHARMACEUTICALS
Industry:
Biotechnology Health Care Medical
Address:
Knoxville, Tennessee, United States
Country:
United States
Website Url:
http://www.provectusbio.com
Total Employee:
1+
Status:
Active
Contact:
(800) 733-1121
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Official Site Inspections
http://www.provectusbio.com Semrush global rank: 5.63 M Semrush visits lastest month: 1.5 K
- Host name: cloudhost-433585.us-midwest-1.nxcli.net
- IP address: 209.87.159.189
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Provectus Biopharmaceuticals"
Board of Directors - Provectus Biopharmaceuticals, Inc.
BOARD OF DIRECTORS. Ed Pershing, CPA – Chairman of the Board and Chief Executive Officer. Mr. Pershing has served as non-executive Chairman of our Board since 2018.See details»
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 800 S Gay St, Suite 1610, Knoxville, TN 37929 (Address of principal executive offices) (Zip Code) …See details»
Provectus Biopharmaceuticals - Crunchbase Company Profile
Provectus Biopharmaceuticals is a clinical-stage biotechnology company that develops new therapies for the treatment of skin cancer, liver cancer, and breast cancer.See details»
Provectus Biopharmaceuticals - Craft
Oct 29, 2024 Provectus Biopharmaceuticals has 5 employees across 2 locations and $557.71 k in annual revenue in FY 2023. See insights on Provectus Biopharmaceuticals including office …See details»
PVCT Company Description - Stock Analysis
Jan 2, 2025 Company profile for Provectus Biopharmaceuticals, Inc. (PVCT) with a description, list of executives, contact details and other key facts.See details»
Provectus Biopharmaceuticals CEO and key executive team - Craft
Provectus Biopharmaceuticals's Chief Operating Officer, Board Member is Bruce Horowitz. Other executives include Ed Pershing, Chairman of the Board; Eric Wachter, Chief Technology …See details»
Provectus Biopharmaceuticals - Overview, News & Similar
Apr 18, 2024 Who is Provectus Biopharmaceuticals. Provectus Biopharmaceuticals, Inc. (Provectus or the Company) is a clinical-stage biotechnology company developing …See details»
Provectus Biopharmaceuticals - VentureRadar
"Provectus is a clinical-stage biotechnology company developing immunotherapy medicines based on small molecules called halogenated xanthenes, the entire class of which is owned by …See details»
Leadership - Provectus Biopharmaceuticals, Inc.
MANAGEMENT. Ed Pershing, CPA, Chief Executive Officer. Mr. Pershing has served as non-executive Chairman of our Board since 2018. He was the Chief Executive Officer of Pershing …See details»
Provectus Biopharmaceuticals Company Profile -Sales, Contacts ...
Provectus Biopharmaceuticals is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 47 years.See details»
Provectus Biopharmaceuticals Announces Exclusive Worldwide
Mar 27, 2024 In 2022, the International Nonproprietary Names (“INN”) Expert Committee of the World Health Organization (the “WHO”) selected RBS for the nonproprietary name of the …See details»
Provectus Biopharmaceuticals Appoints Bruce Horowitz And …
KNOXVILLE, Tenn., Feb. 23, 2017 /PRNewswire/ -- Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) (www.provectusbio.com) ("Provectus" or the "Company"), a clinical-stage oncology and …See details»
Provectus’s Substack | Provectus Biopharmaceuticals | Substack
A clinical-stage biotechnology company developing immunotherapy medicines for different diseases based on a class of synthetic small molecule halogenated xanthenes, with lead …See details»
Provectus Pharmaceuticals - Crunchbase Company Profile & Funding
Provectus Pharmaceuticals focuses on creating sophisticated medicines to target and eliminate the most lethal cancers. Provectus also creates ground-breaking biotechnologies to improve …See details»
Investors - Provectus Biopharmaceuticals, Inc.
I would like to receive investor related information about Provectus Biopharmacuticals. Financial Overview. Clinical TrialsSee details»
Company Provectus Biopharmaceuticals, Inc. - MarketScreener.com
Apr 2, 2017 Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing immunotherapy medicines for different diseases that are …See details»
Provectus Biofuels, Inc. - Cleanest Fuels on Earth | Clean energy ...
Provectus Biofuels Inc. is a clean energy technology developer incorporated in British Columbia. We integrate our licensed patented process technology with proven advancements in …See details»
Corporate Presentation - Provectus Biopharmaceuticals, Inc.
I would like to receive investor related information about Provectus Biopharmacuticals. Corporate Presentation. Igniting the Embers of HopeSee details»
Herbalife to Acquire Assets of Pro2col Health and Pruvit Ventures, …
Mar 12, 2025 Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced it has entered into a binding memorandum of unders...See details»
Press Releases - Provectus Biopharmaceuticals, Inc.
Apr 18, 2024 PRESS RELEASES January 14, 2025 Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus’s Spinoff Company for Rose Bengal-Based Eye Drugs …See details»